Cited by

• Revised classification of neuroendocrine tumours of the lung, pancreas and gut.

  Capella C, Heitz PU, Höfler H, Solcia E, Klöppel G. Capella C, et al. Virchows Arch. 1995;425(6):547-60. doi: 10.1007/BF00199342. Virchows Arch. 1995. PMID: 7697211 Review.
• Expression of the C-terminal peptide of human pro-bombesin in 361 lung endocrine tumours, a reliable marker and possible prognostic indicator for small cell carcinoma.

  Hamid QA, Addis BJ, Springall DR, Ibrahim NB, Ghatei MA, Bloom SR, Polak JM. Hamid QA, et al. Virchows Arch A Pathol Anat Histopathol. 1987;411(2):185-92. doi: 10.1007/BF00712743. Virchows Arch A Pathol Anat Histopathol. 1987. PMID: 3037770
• Chromogranin A and B and secretogranin II in bronchial and intestinal carcinoids.

  Weiler R, Feichtinger H, Schmid KW, Fischer-Colbrie R, Grimelius L, Cedermark B, Papotti M, Bussolati G, Winkler H. Weiler R, et al. Virchows Arch A Pathol Anat Histopathol. 1987;412(2):103-9. doi: 10.1007/BF00716181. Virchows Arch A Pathol Anat Histopathol. 1987. PMID: 2447696
• Immunohistochemical demonstration of chromogranin A, chromogranin B, and secretoneurin in primary non-small-cell carcinomas of the lung.

  Tötsch M, Kunk B, Dockhorn-Dworniczak B, Öfner D, Fischer-Colbrie R, Mikuz G, Böcker W, Schmid KW. Tötsch M, et al. Endocr Pathol. 1994 Dec;5(4):212-217. doi: 10.1007/BF02921488. Endocr Pathol. 1994. PMID: 32138452
• Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro.

  Weber S, Zuckerman JE, Bostwick DG, Bensch KG, Sikic BI, Raffin TA. Weber S, et al. J Clin Invest. 1985 Jan;75(1):306-9. doi: 10.1172/JCI111690. J Clin Invest. 1985. PMID: 2981251 Free PMC article.